Literature DB >> 10506231

Rehospitalization for respiratory syncytial virus among premature infants.

S Joffe1, G J Escobar, S B Black, M A Armstrong, T A Lieu.   

Abstract

OBJECTIVES: New interventions to prevent respiratory syncytial virus (RSV) have recently become available. Clinical decisions about the use of these interventions require a better understanding of the incidence of and risk factors for RSV. We sought to characterize the epidemiology of severe RSV disease among premature infants and to identify high-risk subgroups.
DESIGN: Retrospective cohort.
SETTING: Kaiser Permanente Northern California, July 1992 to April 1996. PARTICIPANTS: One thousand seven hundred twenty-one premature infants born at 23 to 36 weeks who were discharged from a neonatal intensive care nursery (NICU) within 12 months before the December to March RSV season. A secondary analysis included 769 infants discharged during the RSV season. OUTCOME MEASURES: Hospitalization for RSV.
RESULTS: Of 1721 infants already home from the NICU at the start of the season, 3.2% were rehospitalized for RSV. In a multivariate model, risk factors for RSV hospitalization included gestation </=32 weeks (odds ratio [OR], 2.6), >/=28 days of perinatal oxygen (OR, 3.7), and NICU discharge during September to November (OR, 2.7). Predicted risk of hospitalization varied by subgroup, ranging from 1.2% to 24.6%. Among 769 infants discharged from the NICU during the RSV season, 3.5% were rehospitalized for RSV during the same season; gestation and perinatal oxygen were not associated with admission.
CONCLUSIONS: Most premature infants in this population were at less risk of severe RSV disease than previous studies in other populations have suggested. Preterm infants with a lower gestational age, a prolonged perinatal oxygen requirement, and NICU discharge within 3 months of the RSV season were most likely to require hospitalization for RSV disease. Cost-effectiveness analyses are needed to help define the role of available prophylactic interventions.

Entities:  

Mesh:

Year:  1999        PMID: 10506231     DOI: 10.1542/peds.104.4.894

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  33 in total

1.  Risk factors for hospitalization due to respiratory syncytial virus infection among infants in the Basque Country, Spain.

Authors:  G Cilla; A Sarasua; M Montes; N Arostegui; D Vicente; E Pérez-Yarza; E Pérez-Trallero
Journal:  Epidemiol Infect       Date:  2006-06       Impact factor: 2.451

2.  Hospital admission of high risk infants for respiratory syncytial virus infection: implications for palivizumab prophylaxis.

Authors:  T Heikkinen; H Valkonen; L Lehtonen; R Vainionpää; O Ruuskanen
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2005-01       Impact factor: 5.747

3.  Time to send the preemie home? Additional maturity at discharge and subsequent health care costs and outcomes.

Authors:  Jeffrey H Silber; Scott A Lorch; Paul R Rosenbaum; Barbara Medoff-Cooper; Susan Bakewell-Sachs; Andrea Millman; Lanyu Mi; Orit Even-Shoshan; Gabriel J Escobar
Journal:  Health Serv Res       Date:  2008-12-31       Impact factor: 3.402

4.  Respiratory syncytial virus infection in high risk infants and the potential impact of prophylaxis in a United Kingdom cohort.

Authors:  S J Clark; M W Beresford; N V Subhedar; N J Shaw
Journal:  Arch Dis Child       Date:  2000-10       Impact factor: 3.791

5.  Health care utilisation of infants with chronic lung disease, related to hospitalisation for RSV infection.

Authors:  A Greenough; S Cox; J Alexander; W Lenney; F Turnbull; S Burgess; P A Chetcuti; N J Shaw; A Woods; J Boorman; S Coles; J Turner
Journal:  Arch Dis Child       Date:  2001-12       Impact factor: 3.791

6.  Diminished lung function, RSV infection, and respiratory morbidity in prematurely born infants.

Authors:  S Broughton; R Bhat; A Roberts; M Zuckerman; G Rafferty; A Greenough
Journal:  Arch Dis Child       Date:  2005-09-27       Impact factor: 3.791

7.  Predictors and incidence of hospitalization due to respiratory syncytial virus (RSV)-associated lower respiratory tract infection (LRTI) in non-prophylaxed moderate-to-late preterm infants in Bosnia and Herzegovina.

Authors:  Hajrija Maksić; Suada Heljić; Fahrija Skokić; Darinka Šumanović-Glamuzina; Veroslava Milošević; Almir Zlatanović; Notario Gerard
Journal:  Bosn J Basic Med Sci       Date:  2018-08-01       Impact factor: 3.363

8.  The role of outpatient facilities in explaining variations in risk-adjusted readmission rates between hospitals.

Authors:  Scott A Lorch; Michael Baiocchi; Jeffrey H Silber; Orit Even-Shoshan; Gabriel J Escobar; Dylan S Small
Journal:  Health Serv Res       Date:  2009-09-24       Impact factor: 3.402

9.  The clinical and health economic burden of respiratory syncytial virus disease among children under 2 years of age in a defined geographical area.

Authors:  S A Deshpande; V Northern
Journal:  Arch Dis Child       Date:  2003-12       Impact factor: 3.791

10.  Palivizumab: a review of its use in the protection of high risk infants against respiratory syncytial virus (RSV).

Authors:  Joseph M Geskey; Neal J Thomas; Gretchen L Brummel
Journal:  Biologics       Date:  2007-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.